GLP-1 Drugs and Male Fertility: 2026 Research

_{GLP-1 drugs and male fertility: These medications could help male patients improve their testosterone levels and their fertility, a new study has found.}

GLP-1 medications have transformed the conversation around obesity and metabolic health.

They are widely used to help eligible patients manage obesity and type 2 diabetes. Now researchers are asking whether the benefits of improving metabolic health may extend to another important area: male reproductive health.

New research presented at the Endocrine Society’s ENDO 2026 meeting in Chicago offers encouraging evidence.

A systematic review of randomized controlled trials found that GLP-1 receptor agonists did not appear to harm male reproductive hormones or sperm quality. Some studies also reported improvements in testosterone, sperm morphology or other reproductive measures in men with obesity.

But there is an important qualification.

GLP-1 drugs are not currently approved as male fertility treatments.

The evidence is promising, but researchers say larger and better-designed studies are still needed.

What Did the 2026 Research Find?

Researchers from University Hospitals Coventry and Warwickshire and Warwick Medical School reviewed randomized controlled trials involving men aged 18 to 65 who received GLP-1 receptor agonists.

Five randomized controlled trials met the review criteria.

The studies examined outcomes including:

Testosterone
Luteinizing hormone
Follicle-stimulating hormone
Sex hormone-binding globulin
Semen quality
Sperm concentration
Sperm morphology
Body weight
Blood glucose
Cholesterol

The overall findings were encouraging.

The researchers concluded that GLP-1 receptor agonists did not appear to suppress the male reproductive hormone system and may improve some reproductive measures in men with obesity-related metabolic problems.

However, the studies were relatively small and varied in design.

What Happened to Testosterone?

One of the most interesting findings involved testosterone.

In a 16-week study of men with obesity-related functional hypogonadism, liraglutide was associated with increases in testosterone and related reproductive hormones.

The findings suggest that treating the underlying metabolic problem may help improve hormone function in some men.

This is different from simply giving testosterone from outside the body.

The goal is to understand whether improving metabolic health and reducing excess weight can help the body restore more normal hormone production.

What About Sperm Quality?

The research also produced encouraging findings involving semen parameters.

A 24-week semaglutide study found improvement in sperm morphology while testosterone and other reproductive hormones remained preserved.

Another liraglutide study reported improvements in sperm concentration and total sperm count.

However, these findings should not be interpreted as proof that GLP-1 drugs increase fertility in every man.

Sperm production is influenced by many factors, including age, obesity, metabolic health, hormones, medications, lifestyle and underlying reproductive conditions.

Why Could Weight Loss Improve Male Fertility?

Obesity can affect male reproductive health in several ways.

Excess body fat is associated with metabolic dysfunction and can be linked with hormonal changes.

Weight reduction may improve:

Insulin sensitivity
Metabolic health
Hormonal balance
Cardiovascular health
Inflammation
Body composition

These changes may create a better environment for normal reproductive function.

This is one reason researchers believe that some of the reproductive benefits observed with GLP-1 treatment may be indirect effects of weight loss and improved metabolic health rather than a direct fertility effect of the medication.

Could GLP-1 Drugs Directly Affect the Testes?

Researchers are investigating that possibility.

GLP-1 receptors have been identified in reproductive tissues, and laboratory and preclinical research has suggested potential effects on reproductive pathways.

However, evidence from laboratory studies cannot automatically be translated into proven benefits for humans.

The current human evidence is more limited.

Therefore, it is premature to say that GLP-1 medications directly improve sperm production through a specific testicular mechanism.

Are GLP-1 Drugs a Treatment for Male Infertility?

No.

This is one of the most important points for readers.

GLP-1 medications are prescribed for approved indications such as obesity and type 2 diabetes, depending on the specific medicine.

They have not been established as standard treatments for male infertility.

A man experiencing difficulty conceiving should receive an appropriate fertility evaluation rather than using a GLP-1 medication specifically for fertility.

A reproductive urologist or other qualified specialist can investigate sperm production, hormones, anatomy, medications and other potential causes.

What About Testosterone Replacement?

This is another area where men need to be careful.

Testosterone replacement therapy can increase testosterone levels, but it can also suppress the body’s own reproductive hormone signaling and reduce sperm production.

The American Society for Reproductive Medicine states that exogenous testosterone should be avoided in men attempting conception because it can suppress spermatogenesis.

Therefore, a man concerned about both low testosterone and fertility should not assume that testosterone replacement is automatically the best solution.

A proper hormonal evaluation is important.

Could Treating Obesity Be Better Than Treating Testosterone Alone?

In some men with obesity-related low testosterone, addressing excess weight and metabolic health may improve hormone function.

This is one of the important ideas emerging from the 2026 research.

The Endocrine Society researchers suggested that improving metabolic health may restore hormone levels in some men without directly replacing testosterone.

That does not mean testosterone therapy is never appropriate.

It means doctors need to identify the underlying cause of low testosterone before choosing treatment.

What Are the Limitations of the Evidence?

The findings are encouraging, but the evidence is still developing.

The 2026 review included only five randomized controlled trials.

The studies differed in their design, participants and outcomes.

Some examined reproductive hormones, while others examined semen characteristics.

The researchers therefore emphasized the need for larger trials specifically designed to measure male reproductive outcomes.

This is particularly important because an improvement in testosterone or sperm morphology does not automatically mean a higher chance of achieving pregnancy.

What Can Men Do to Support Fertility?

Medication is only one part of reproductive health.

Evidence-based lifestyle measures can also help support overall metabolic and reproductive health.

Useful habits include:

Maintaining a healthy weight
Exercising regularly
Eating a balanced diet
Limiting highly processed foods
Avoiding tobacco
Limiting excessive alcohol
Avoiding unnecessary heat exposure to the testicles
Managing metabolic conditions
Getting appropriate medical evaluation when conception is difficult

Men planning a family should also discuss prescription medicines and supplements with their healthcare professional.

When Should a Man Have a Fertility Evaluation?

A fertility evaluation may be appropriate when a couple has been trying to conceive without success or when there are known reproductive concerns.

A physician may assess:

Medical history
Sexual function
Physical findings
Semen analysis
Testosterone
FSH and other reproductive hormones
Medications
Metabolic health

The American Society for Reproductive Medicine recommends appropriate hormonal evaluation in infertile men with conditions such as impaired libido, erectile dysfunction, low sperm counts or suspected hormonal abnormalities.

These findings add to the growing evidence surrounding GLP-1 medications and weight loss and their potential effects beyond body weight.

What Does the Research Mean for Men Taking GLP-1 Drugs?

The 2026 evidence provides some reassurance.

The available clinical trials do not suggest that GLP-1 receptor agonists generally damage male reproductive hormones or sperm quality.

In some men with obesity, the medicines may even be associated with improvements in testosterone or semen parameters.

But that is different from saying:

“GLP-1 drugs improve male fertility.”

The more accurate conclusion is:

GLP-1 treatment may improve some reproductive health measures in men with obesity, particularly as metabolic health and body weight improve, but more research is needed to determine whether this translates into better fertility outcomes.

The Bigger Picture

The new fertility research adds to the expanding scientific interest in GLP-1 medications.

These medicines were initially associated mainly with blood-sugar control and weight loss.

Researchers are now studying how improving metabolic health may influence multiple systems throughout the body.

Male reproductive health could become another important area of investigation.

But responsible health reporting requires separating promising early findings from established medical treatment.

Final Takeaway

The latest 2026 research provides encouraging news for men with obesity who are concerned about testosterone and reproductive health.

Clinical trials reviewed by researchers found that GLP-1 receptor agonists did not appear to harm male reproductive hormones or sperm quality. Some studies also found improvements in testosterone, sperm morphology or other semen parameters.

However, GLP-1 drugs are not currently fertility treatments.

For men trying to conceive, the priority should be a proper medical evaluation and treatment of the underlying cause of fertility problems.

The most promising message from the research may be that improving metabolic health and reducing excess weight could have benefits that extend beyond the number on the scale.

Frequently Asked Questions

Can GLP-1 drugs increase testosterone?

Early research suggests that GLP-1 treatment may improve testosterone levels in some men with obesity-related low testosterone. The effect is not universal and more research is needed.

Can GLP-1 drugs improve sperm quality?

Some clinical studies have reported improvements in semen parameters, including sperm morphology and concentration. However, the evidence remains limited.

Does semaglutide improve male fertility?

A 24-week semaglutide study found improved sperm morphology while reproductive hormone levels were preserved. This does not prove that semaglutide is a fertility treatment.

Can men take GLP-1 drugs while trying to have children?

Men should discuss their individual medicines and fertility plans with their healthcare professional. GLP-1 drugs should not be started specifically as a fertility treatment without medical advice.

Can testosterone replacement reduce sperm count?

Yes. Exogenous testosterone can suppress the body’s reproductive hormone signaling and reduce or even stop sperm production. Men attempting conception should discuss this issue with a qualified fertility specialist before using testosterone therapy.

Are GLP-1 drugs approved for male infertility?

No. They are not established or approved as standard treatments for male infertility.

Medical note: This article discusses emerging research and is not medical advice. Men experiencing fertility problems should seek evaluation from a qualified physician or reproductive specialist.

GLP-1 Drugs and Male Fertility: What Researchers Know in 2026